ZUG, Switzerland, Dec. 17, 2024 /PRNewswire/ — Token Recovery, a specialist end-to-end digital asset recovery company has announced its partnership with CYBERA, a leading provider in scam prevention and response solutions. This collaboration strengthens CYBERA’s offering, enabling them…
Tag: PR Newswire
ZUG, Switzerland, Dec. 17, 2024 /PRNewswire/ — Token Recovery, a specialist end-to-end digital asset recovery company has announced its partnership with CYBERA, a leading provider in scam prevention and response solutions. This collaboration strengthens CYBERA’s offering, enabling them…
BEIJING, Dec. 17, 2024 /PRNewswire/ — Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China’s brands favored by foreigners in 2024 at the 2024 China Brand Day…
BEIJING, Dec. 17, 2024 /PRNewswire/ — Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China’s brands favored by foreigners in 2024 at the 2024 China Brand Day…
BEIJING, Dec. 17, 2024 /PRNewswire/ — Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China’s brands favored by foreigners in 2024 at the 2024 China Brand Day…
GlycoNex developing denosumab biosimilar, SPD8, for the treatment of osteoporosis NEW TAIPEI CITY, Taiwan, Dec. 17, 2024 /PRNewswire/ — GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer…
GlycoNex developing denosumab biosimilar, SPD8, for the treatment of osteoporosis NEW TAIPEI CITY, Taiwan, Dec. 17, 2024 /PRNewswire/ — GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer…
GlycoNex developing denosumab biosimilar, SPD8, for the treatment of osteoporosis NEW TAIPEI CITY, Taiwan, Dec. 17, 2024 /PRNewswire/ — GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer…
SAN JOSE, Calif., Dec. 17, 2024 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP, ruggedized FPGAs, and endpoint AI solutions, today announced the appointment of Andy Jaros as Vice President of IP Sales, effective immediately. Andy will…
SAN JOSE, Calif., Dec. 17, 2024 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP, ruggedized FPGAs, and endpoint AI solutions, today announced the appointment of Andy Jaros as Vice President of IP Sales, effective immediately. Andy will…
